The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA mulls compounding for peptides previously flagged over safety risks BioSpace Is BPC 157 Legal? Understanding Its Status and Implications Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law